ABSI
Price
$1.32
Change
-$0.06 (-4.35%)
Updated
Sep 29, 6:59 PM EST
40 days until earnings call
BEAM
Price
$24.05
Change
+$0.03 (+0.12%)
Updated
Sep 29, 6:59 PM EST
37 days until earnings call

Analysis and predictions ABSI vs BEAM

Header iconABSI vs BEAM Comparison
Open Charts ABSI vs BEAMBanner chart's image
Absci
Price$1.32
Change-$0.06 (-4.35%)
Volume$123K
CapitalizationN/A
Beam Therapeutics
Price$24.05
Change+$0.03 (+0.12%)
Volume$477.92K
CapitalizationN/A
View a ticker or compare two or three
ABSI vs BEAM Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
ABSI vs. BEAM commentary
Sep 30, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a StrongBuy and BEAM is a StrongBuy.

COMPARISON
Comparison
Sep 30, 2023
Stock price -- (ABSI: $1.38 vs. BEAM: $24.05)
Brand notoriety: ABSI and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 53% vs. BEAM: 91%
Market capitalization -- ABSI: $127.94M vs. BEAM: $1.9B
ABSI [@Biotechnology] is valued at $127.94M. BEAM’s [@Biotechnology] market capitalization is $1.9B. The market cap for tickers in the [@Biotechnology] industry ranges from $410.54B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 1 FA rating(s) are green whileBEAM’s FA Score has 0 green FA rating(s).

  • ABSI’s FA Score: 1 green, 4 red.
  • BEAM’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than ABSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 4 TA indicator(s) are bullish while BEAM’s TA Score has 5 bullish TA indicator(s).

  • ABSI’s TA Score: 4 bullish, 5 bearish.
  • BEAM’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than ABSI.

Price Growth

ABSI (@Biotechnology) experienced а -7.38% price change this week, while BEAM (@Biotechnology) price change was +1.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.08%. For the same industry, the average monthly price growth was +16.82%, and the average quarterly price growth was +35.61%.

Reported Earning Dates

ABSI is expected to report earnings on Nov 08, 2023.

BEAM is expected to report earnings on Nov 06, 2023.

Industries' Descriptions

@Biotechnology (+2.08% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ABSI with price predictions.
OPEN
A.I.dvisor published
a Summary for BEAM with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BEAM($1.9B) has a higher market cap than ABSI($128M). ABSI YTD gains are higher at: -34.286 vs. BEAM (-38.507). ABSI has higher annual earnings (EBITDA): -97.42M vs. BEAM (-364.48M). BEAM has more cash in the bank: 1.07B vs. ABSI (125M). ABSI has less debt than BEAM: ABSI (19.5M) vs BEAM (175M). BEAM has higher revenues than ABSI: BEAM (80.2M) vs ABSI (8.56M).
ABSIBEAMABSI / BEAM
Capitalization128M1.9B7%
EBITDA-97.42M-364.48M27%
Gain YTD-34.286-38.50789%
P/E RatioN/AN/A-
Revenue8.56M80.2M11%
Total Cash125M1.07B12%
Total Debt19.5M175M11%
TECHNICAL ANALYSIS
Technical Analysis
ABSIBEAM
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 1 day ago
68%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRESX22.190.08
+0.36%
T. Rowe Price European Stock
EQICX9.89N/A
N/A
Allspring Emerging Markets Eq Inc C
SFDYX25.45N/A
N/A
SEI Mid-Cap Y (SIMT)
RMFHX47.76-0.22
-0.46%
American Funds American Mutual R5E
FVDFX33.44-0.20
-0.59%
Fidelity® Value Discovery

ABSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABSI has been loosely correlated with RXRX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ABSI jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABSI
1D Price
Change %
ABSI100%
+2.22%
RXRX - ABSI
49%
Loosely correlated
-0.13%
DNA - ABSI
48%
Loosely correlated
-3.37%
NTLA - ABSI
47%
Loosely correlated
-1.03%
BEAM - ABSI
46%
Loosely correlated
-0.99%
VCYT - ABSI
45%
Loosely correlated
+0.22%
More